W.). 220-kDa heparan sulfate proteoglycan (4). The binding of LPL to cultured endothelial cells can be reduced by removing HSPGs from the surface of cells (5). LPL can be released from its binding sites by heparin (6), and mutation of the principal heparin-binding domain of LPL reduces LPL binding to Continue Reading